Loading clinical trials...
Loading clinical trials...
The aim of this open, controlled, multicentre biomedical research study is to identify new markers specifically associated with Horton's disease. This would make it possible to improve the diagnosis and management of this disease. Participation consists in taking one or several blood samples depending on the group patients/controls.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
Yes
CHU de BESANCON
Besançon, France
CHU de DIJON
Dijon, France
CH de METZ
Metz, France
Start Date
July 28, 2009
Primary Completion Date
January 7, 2016
Last Updated
May 6, 2019
143
ACTUAL participants
1 blood sample
OTHER
2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse)
OTHER
Lead Sponsor
Centre Hospitalier Universitaire Dijon
NCT07069400
NCT04712851
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07347015